Bowen Hanes & Co. Inc. Buys 4,680 Shares of Intuitive Surgical, Inc. $ISRG

Bowen Hanes & Co. Inc. grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 179,190 shares of the medical equipment provider’s stock after purchasing an additional 4,680 shares during the quarter. Intuitive Surgical comprises about 2.5% of Bowen Hanes & Co. Inc.’s investment portfolio, making the stock its 8th biggest position. Bowen Hanes & Co. Inc.’s holdings in Intuitive Surgical were worth $101,486,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Shepherd Street Advisors LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $1,102,000. CIBC Asset Management Inc grew its stake in Intuitive Surgical by 25.0% in the 4th quarter. CIBC Asset Management Inc now owns 199,386 shares of the medical equipment provider’s stock valued at $112,924,000 after buying an additional 39,820 shares during the last quarter. Marble Wealth LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $957,000. Rational Advisors Inc. grew its stake in Intuitive Surgical by 46.7% in the 4th quarter. Rational Advisors Inc. now owns 1,665 shares of the medical equipment provider’s stock valued at $943,000 after buying an additional 530 shares during the last quarter. Finally, Harfst & Associates Inc. grew its stake in Intuitive Surgical by 1.8% in the 4th quarter. Harfst & Associates Inc. now owns 3,167 shares of the medical equipment provider’s stock valued at $1,794,000 after buying an additional 56 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Piper Sandler reiterated its Buy rating on Intuitive Surgical, which helps support the case that Wall Street still sees upside in the company’s robotic surgery franchise. Article Title
• Positive Sentiment: Commentary highlighted Intuitive Surgical’s AI-driven digital roadmap and da Vinci 5 adoption as potential long-term growth drivers, suggesting its robotics ecosystem still has room to expand. Article Title
• Neutral Sentiment: Several articles simply noted that ISRG has been a weak performer recently and raised the question of a rebound; these pieces did not provide a fresh catalyst. Article Title
• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical to $366 from $440 and kept a Sell rating, reinforcing concerns that the shares may still have downside from current levels. Article Title
• Negative Sentiment: SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 transaction, which can still weigh on sentiment because it reduces insider ownership and may be viewed cautiously by investors. Article Title
• Negative Sentiment: Market coverage also said ISRG underperformed peers and the broader healthcare group, adding to the narrative that the stock has lost momentum recently. Article Title

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ISRG shares. TD Cowen lowered their target price on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price on the stock in a research note on Wednesday, March 11th. Robert W. Baird raised their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $573.63.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total transaction of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 7,448 shares of company stock worth $3,224,404. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $407.29 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The firm has a fifty day moving average price of $449.26 and a two-hundred day moving average price of $502.50. The company has a market cap of $144.25 billion, a PE ratio of 49.37, a price-to-earnings-growth ratio of 3.21 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the prior year, the firm earned $1.81 EPS. The business’s revenue was up 23.0% on a year-over-year basis. Analysts expect that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.